The usefulness of kestose for ulcerative colitis

Honda Takashi0 个研究点目标入组 40 人开始时间: 2019年4月10日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方: Honda Takashi
入组人数: 40

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

The oral intake of 1-kestose provides clinical and endoscopic improvement for patients with mild to moderate UC through the modulation of gut microbiome and is well tolerated.

研究设计

研究类型: Interventional

入排标准

年龄范围: >= 20age old 至 <= 80age old（—）
性别: All

入选标准

•Patients with active ulcerative colitis (Lichtiger CAI>3)

排除标准

•1.Women with pregnancy or possible pregnancy
•2.Patients with severe renal failure and heart failure
•3.Patient who is considered to be inappropriate for entry into the trial by the investigator
•4.Medical doctors decided the patients are inappropriate.

研究者

发起方

Honda Takashi

相似试验

已完成

4 期

Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative ColitisUlcerative Colitis

NCT01941589Sheba Medical Center149

已完成

不适用

Improvement of treatment in ulcerative colitis, severe case and moderate case close to severe case, by early use of infliximabulcerative colitis

JPRN-UMIN000020402IBD Relapse Prevention Team50

已完成

3 期

Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).Ulcerative Colitis

NCT02665845Centre Hospitalier Universitaire de Saint Etienne160

已完成

不适用

Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study)Colitis, UlcerativeInflammatory Bowel Diseases

NCT01534312University of Aarhus24

招募中

1 期

A novel treatment for ulcerative colitis with purastatlcerative colitisInflammatory bowel diseaseD003093

JPRN-jRCTs032230119Hashimoto Yu20